Long Term Physical Functional Limitations in Daily Living in SARS-CoV2 Infected Patients Hospitalized in the Acute Phase Then Requiring Rehabilitation (CAPACoV19)

CHU de Reims

Status: Completed

Conditions: Infection With Coronavirus SARS-CoV2

Treatments: Other: Data record

Study type: Observational

Funder types: Other

Identifiers

NCT04356378

PO20055

Details and patient eligibility

About

Infection with coronavirus SARS-CoV2 (COVID-19 disease) is unique with its speed of propagation, structural medical reorganizations and length of stay in intensive care needed, diversity of the affected population (in particular between young persons or fragile subjects), and impact on physical and mental health generated by confinement of populations.

Fatigue is a major component of COVID-19. Global muscular weakness is related to immobility, inflammation, corticosteroids treatment, hypoxemia due to pulmonary and/or cardiac infectious attacks and undernutrition suggests major physical functional repercussions. Thus, patients affected by COVID-19 with acute hospital management require sometimes complex rehabilitation management.

Retrospective studies on physical functional capacities in patients infected with SARS CoV1 showed long term physical activity limitations.

Full description

The aim of this study is to study factors associated with physical functional limitations in daily living in patients SARS-CoV2 infected and hospitalized in the acute phase then requiring rehabilitation.

Enrollment: 149 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria :

• patient infected with SARS-CoV2
• in-patient hospitalization in the acute phase because SARS-CoV2 infection
• patient requiring rehabilitation after SARS-CoV2 infection acute phase
• patient adult, aged more than 18 years old
• patient accepting to participate in the study

Exclusion criteria :

• patient with cognitive disorder (Folstein Mini-Mental State Examination less than 22 on 30 points)

Trial design

149 participants in 1 patient group

"infection with coronavirus SARS-CoV2" group

Description:

"SARS-CoV2 infected patients" group: in-patient in the acute phase then requiring rehabilitation.

Treatment:

Other: Data record